Kyverna Therapeutics, Inc. Common Stock (KYTX)
Healthcare
Biotechnology
7.30 $
-2.5%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Kyverna Therapeutics, Inc. Common Stock (KYTX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 58.5% of the shares are freely tradable; institutional investors hold 74.3%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
74.3%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
7.1%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
58.5%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
15.2%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
61Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| GordonMD Global Investments LP | 6.98 | 4,244,818 | -3.3 | 03/31/2026 |
| Bain Capital Life Sciences Investors, LLC | 5.12 | 3,110,000 | +0.0 | 03/31/2026 |
| AIGH Capital Management, LLC | 3.29 | 2,000,000 | +33.3 | 03/31/2026 |
| Deerfield Management Co | 3.29 | 2,000,000 | +0.0 | 03/31/2026 |
| Vanguard Capital Management, LLC | 2.93 | 1,783,342 | +0.0 | 03/31/2026 |
| T. Rowe Price Associates, Inc. | 2.56 | 1,555,287 | -11.8 | 03/31/2026 |
| Balyasny Asset Management LLC | 1.85 | 1,125,321 | +14.7 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| MEDICAL BioHealth EUR Acc | 2.49 | 1,513,589 | +15.4 | 06/30/2026 |
| Vanguard Morn Total Stk Mkt Idx Investor | 2.31 | 1,403,697 | +4.2 | 06/30/2026 |
| iShares Russell 2000 ETF | 1.76 | 1,068,962 | -0.1 | 07/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.